Cell Therapy Biomanufacturing: Global Markets

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Market Estimates
Information Sources

• Primary Research
• Secondary Research

Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Introduction

Chapter 3 Market and Technology Background

Introduction to Cell Therapy Biomanufacturing
What is Cell Therapy?
Stem Cell Transplantation

• Autologous
• Allogeneic
• Syngeneic

Stem Cell Biomanufacturing and Classification

• Based on Ability to Differentiate
• Based on Source

Classification of Cell-Based Therapy Technology

• Somatic Cell Technologies
• Three-Dimensional Technologies
• Cell Immortalization Technologies
• Genome Editing Technologies
• Cell Plasticity Technologies
• Ex vivo Gene Modification of Cells Using Viral Vector Technologies
• In vivo Gene Modification of Cells Using Viral Vector Technologies

Stem Cell Applications
Mechanism of Cell Therapy
Delivery Method of Cell-Based Therapy
Manufacturing Cell Therapy Models
Role of Contract Manufacturers
Ongoing Clinical Trials

• Clinical Trial Network Focused on Stem Cell Treatments

Chapter 4 Market Trends and Challenges

Challenges

• Drivers
• Restraints
• Opportunity

Chapter 5 Market Breakdown by Product Type

Type of Therapy
Source of Cells

• Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy

Chapter 6 Market Breakdown by Application

Cardiovascular Disease

• Microparticles Cell Imitation

Bone Repair
Neurological Disorders

• Spinal Cord Injury
• Stroke
• Parkinson’s Disease
• Amyotrophic Lateral Sclerosis
• Multiple Sclerosis
• Cerebral Palsy
• Alzheimer's Disease
• Vision Restoration
• Vertebral Repair
• Batten's Disease

Skeletal Muscle Repair

• Intrinsic Healing Mechanisms
• Cell Therapy Mechanism
• Cancer

Other Diseases

Chapter 7 Market Breakdown by Region

Market Overview
North America

• U.S.
• Canada
• Mexico

Europe

• Cardiovascular Diseases in Europe
• Contributing Factors for Cardiovascular Diseases (CVD)
• Germany
• U.K.
• France

Asia-Pacific

• China
• India
• Japan
• Rest of APAC

Rest of the World

• South America
• Middle East and Africa

Chapter 8 Regulatory Structure

FDA Approvals
Cell Therapy for CBER Regulations

• Federal Regulation codes
• Collection of Cells
• Code of Regulation
• Legislation Governing Use of Stem Cell Treatments
• EU Determination of Regulatory Status
• Regulatory Scenario in India

Chapter 9 Company Profiles

BONE THERAPEUTICS SA
BRISTOL-MYERS SQUIBB CO.
CALADRIUS BIOSCIENCES INC.
CELL THERAPIES PTY LTD.
CELLULAR BIOMEDICINE GROUP INC.
IOVANCE BIOTHERAPEUTICS INC.
LONZA GROUP LTD.
MERCK KGAA
NEUROGENERATION INC.
NOVARTIS AG
REGEN BIOPHARMA INC.
REGENEUS LTD.

Chapter 10 Appendix: References

Sources

List of Tables

Summary Table : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
Table 1 : Types of Stem Cells
Table 2 : Global Market for Cell Therapy Biomanufacturing, by Type of Therapy, Through 2025
Table 3 : Global Market for Cell Therapy Biomanufacturing, by Source of Cells, Through 2025
Table 4 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025
Table 5 : Treatments for Cardiovascular Diseases
Table 6 : Global Market for Cell Therapy Biomanufacturing for Cardiovascular Disease Applications, Through 2025
Table 7 : Global Market for Cell Therapy Biomanufacturing for Bone Repair Applications, Through 2025
Table 8 : Global Market for Cell Therapy Biomanufacturing for Neurological Disorder Applications, Through 2025
Table 9 : Global Market for Cell Therapy Biomanufacturing for Skeletal Muscle Repair Applications, Through 2025
Table 10 : Global Market for Cell Therapy Biomanufacturing for Cancer Treatment Applications, Through 2025
Table 11 : Global Market for Cell Therapy Biomanufacturing for Other Applications, Through 2025
Table 12 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2025
Table 13 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2025
Table 14 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2025
Table 15 : Stem Cell Treatment Provided in Australia
Table 16 : Bone Therapeutics: Products
Table 17 : Bristol-Myers Squibb: Net Revenue, 2017-2019
Table 18 : Caladrius Biosciences: Products
Table 19 : Iovance Biotherapeutics: Products
Table 20 : Merck KGaA: Products
Table 21 : Regen BioPharma: Products
Table 22 : Regeneus: Products

"List of Figures

Summary Figure : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
Figure 1 : Combination of Stem Cells and Biomaterials
Figure 2 : Global Market for Cell Therapy Biomanufacturing Market, by Product Type, 2019-2025
Figure 3 : Autologous and Allogeneic Cell Therapy Based on Source
Figure 4 : Mechanism of Bone Marrow
Figure 5 : Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
Figure 6 : Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025
Figure 7 : North American Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 8 : North American Market Share for Cell Therapy Biomanufacturing, by Country, 2019
Figure 9 : European Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 10 : European Market Share for Cell Therapy Biomanufacturing, by Country, 2019
Figure 11 : Asia-Pacific Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 12 : Asia-Pacific Market Share for Cell Therapy Biomanufacturing, by Country, 2019
Figure 13 : South American Market for Cell Therapy Biomanufacturing, 2019-2025
Figure 14 : Middle Eastern and African Market for Cell Therapy Biomanufacturing, 2019-2025

当レポートのプレスリリースは発行されておりません。